


The Fund aims to provide a higher yield than that of the FTSE All-Share Index with some long-term growth.
| Name | % Net Assets | 
|---|---|
| BP USD0.25 | 10.8% | 
| Royal Dutch Shell B | 8.2% | 
| GlaxoSmithKline | 7.2% | 
| Vodafone | 7.1% | 
| British American Tobacco | 4.8% | 
| AstraZeneca | 4.8% | 
| Scottish & Southern | 4.5% | 
| HSBC | 4.2% | 
| Rio Tinto | 4.1% | 
| National Grid | 4.0% | 
| Key | % Net Assets | 
|---|---|
| 10.8% | |
| 8.2% | |
| 7.2% | |
| 7.1% | |
| 66.7% | 
| Date | 20-Aug-2025 | 
|---|---|
| NAV | 91.47p | 
| Currency | GBP | 
| Change | 0.22p | 
| % | 0.24% | 
| YTD change | 7.61p | 
| YTD % | 9.07% | 
| Fund Inception | 05/11/1968 | 
|---|---|
| Fund Manager | Julian Cane | 
| TER | 1.80 (30-Apr-2011) | 
| Minimum Investment | |
|---|---|
| Initial | £1000 | 
| Additional | £1,000 | 
| Savings | £50 | 
| Charges | |
|---|---|
| Initial | 5.00% | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.02 | 
| Sharpe ratio | 0.07 | 
You are here: research